Literature DB >> 3382112

Ciprofloxacin and allergic interstitial nephritis.

D J Rippelmeyer, A Synhavsky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3382112     DOI: 10.7326/0003-4819-109-2-170_1

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  9 in total

Review 1.  Quinolone antimicrobial agents: adverse effects and bacterial resistance.

Authors:  J S Wolfson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

Review 2.  Tolerability of fluoroquinolone antibiotics. Past, present and future.

Authors:  P Ball; G Tillotson
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

3.  Typhoid fever, ciprofloxacin, and renal failure.

Authors:  J Simpson; A R Watson; A Mellersh; C S Nelson; K Dodd
Journal:  Arch Dis Child       Date:  1991-09       Impact factor: 3.791

Review 4.  Fluoroquinolone-induced renal failure.

Authors:  B M Lomaestro
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

Review 5.  Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.

Authors:  Michel Daudon; Vincent Frochot; Dominique Bazin; Paul Jungers
Journal:  Drugs       Date:  2018-02       Impact factor: 9.546

Review 6.  Clinical features and management of adverse effects of quinolone antibacterials.

Authors:  J H Paton; D S Reeves
Journal:  Drug Saf       Date:  1991 Jan-Feb       Impact factor: 5.606

Review 7.  Drug-induced renal calculi: epidemiology, prevention and management.

Authors:  Michel Daudon; Paul Jungers
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Post-marketing surveillance of quinolones 1988-1990.

Authors:  P G Davey; T McDonald; G Lindsay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

Review 9.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.